{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "21",
                "@timestamp": "2022-03-21T21:34:09.000009-04:00",
                "@year": "2022",
                "@month": "03"
            },
            "ait:date-sort": {
                "@day": "19",
                "@year": "2021",
                "@month": "08"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": [
                {"xocs:funding-agency-matched-string": "King Chulalongkorn Memorial Hospital Thai Red Cross Society"},
                {
                    "xocs:funding-agency-matched-string": "National Institutes of Health",
                    "xocs:funding-agency-acronym": "NIH",
                    "xocs:funding-agency": "National Institutes of Health",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100000002",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "National Cancer Institute",
                    "xocs:funding-agency-acronym": "NCI",
                    "xocs:funding-agency": "National Cancer Institute",
                    "xocs:funding-id": "P30CA008748",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100000054",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001"
                },
                {
                    "xocs:funding-agency-matched-string": "National Center for Advancing Translational Sciences",
                    "xocs:funding-agency-acronym": "NCATS",
                    "xocs:funding-agency": "National Center for Advancing Translational Sciences",
                    "xocs:funding-id": "UL1TR000457",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100006108",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001"
                },
                {
                    "xocs:funding-agency-matched-string": "Parker Institute for Cancer Immunotherapy",
                    "xocs:funding-agency": "Parker Institute for Cancer Immunotherapy",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100014547",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "Chulalongkorn University",
                    "xocs:funding-agency-acronym": "CU",
                    "xocs:funding-agency": "Chulalongkorn University",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100002873",
                    "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"
                }
            ],
            "xocs:funding-addon-generated-timestamp": "2023-03-01T19:31:00.330950Z",
            "xocs:funding-text": "K.W. receives salary support from the Parker Institute for Cancer Immunotherapy at Memorial Sloan Kettering Cancer Center and King Chulalongkorn Memorial Hospital Thai Red Cross Society, Chulalongkorn University. This work received support from the National Institutes of Health, National Center for Advancing Translational Sciences (grant UL1TR00457; M.B.G.) and the National Cancer Institute (grant P30 CA008748).",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60009343",
                            "@country": "usa",
                            "city": "New York",
                            "organization": [
                                {"$": "Department of Medicine"},
                                {"$": "Memorial Sloan Kettering Cancer Center"}
                            ],
                            "affiliation-id": {
                                "@afid": "60009343",
                                "@dptid": "109501192"
                            },
                            "state": "NY",
                            "@affiliation-instance-id": "S0006497121008442-564cb38510548d118977fe2a25115854",
                            "ce:source-text": "Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY",
                            "@dptid": "109501192"
                        },
                        "author": [{
                            "ce:given-name": "Kitsada",
                            "preferred-name": {
                                "ce:given-name": "Kitsada",
                                "ce:initials": "K.",
                                "ce:surname": "Wudhikarn",
                                "ce:indexed-name": "Wudhikarn K."
                            },
                            "@author-instance-id": "S0006497121008442-10d1275cf452183f0c74e10f5830ac11",
                            "@seq": "1",
                            "ce:initials": "K.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Wudhikarn",
                            "@auid": "37091810400",
                            "@orcid": "0000-0001-9528-8681",
                            "ce:indexed-name": "Wudhikarn K."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Research Unit in Translational Hematology"},
                                {"$": "Division of Hematology"},
                                {"$": "Department of Medicine"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "113019942"
                            },
                            "@affiliation-instance-id": "S0006497121008442-dc2678d2dc1eeb9701cb0108a2736f46",
                            "ce:source-text": "Research Unit in Translational Hematology, Division of Hematology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand",
                            "@dptid": "113019942"
                        },
                        "author": [{
                            "ce:given-name": "Kitsada",
                            "preferred-name": {
                                "ce:given-name": "Kitsada",
                                "ce:initials": "K.",
                                "ce:surname": "Wudhikarn",
                                "ce:indexed-name": "Wudhikarn K."
                            },
                            "@author-instance-id": "S0006497121008442-10d1275cf452183f0c74e10f5830ac11",
                            "@seq": "1",
                            "ce:initials": "K.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Wudhikarn",
                            "@auid": "37091810400",
                            "@orcid": "0000-0001-9528-8681",
                            "ce:indexed-name": "Wudhikarn K."
                        }]
                    },
                    {
                        "affiliation": {
                            "organization": {"$": "Department of Biostatistics and Epidemiology"},
                            "@affiliation-instance-id": "S0006497121008442-6b0d2f3d31f874b1262fb82854a236f0",
                            "ce:source-text": "Department of Biostatistics and Epidemiology"
                        },
                        "author": [
                            {
                                "ce:given-name": "Jessica R.",
                                "preferred-name": {
                                    "ce:given-name": "Jessica R.",
                                    "ce:initials": "J.R.",
                                    "ce:surname": "Flynn",
                                    "ce:indexed-name": "Flynn J.R."
                                },
                                "@author-instance-id": "S0006497121008442-c1b5d63d20a550bb97d124a8e934bce6",
                                "@seq": "2",
                                "ce:initials": "J.R.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Flynn",
                                "@auid": "57203165820",
                                "@orcid": "0000-0001-8310-6684",
                                "ce:indexed-name": "Flynn J.R."
                            },
                            {
                                "ce:given-name": "Mithat",
                                "preferred-name": {
                                    "ce:given-name": "Mithat",
                                    "ce:initials": "M.",
                                    "ce:surname": "GÃ¶nen",
                                    "ce:indexed-name": "GÃ¶nen M."
                                },
                                "@author-instance-id": "S0006497121008442-dc52342dbc7900e53783678aa026864d",
                                "@seq": "4",
                                "ce:initials": "M.",
                                "@date-locked": "2021-12-31T20:37:28.153",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "GÃ¶nen",
                                "@auid": "7003560941",
                                "@orcid": "0000-0001-8683-8477",
                                "ce:indexed-name": "Gonen M."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "@afid": "126765627",
                            "organization": {"$": "Cell Therapy and Cell Engineering Center"},
                            "affiliation-id": {"@afid": "126765627"},
                            "@affiliation-instance-id": "S0006497121008442-817683e672d80a9256e621cd8e7ed235",
                            "ce:source-text": "Cell Therapy and Cell Engineering Center"
                        },
                        "author": [
                            {
                                "ce:given-name": "Isabelle",
                                "preferred-name": {
                                    "ce:given-name": "Isabelle",
                                    "ce:initials": "I.",
                                    "ce:surname": "RiviÃ¨re",
                                    "ce:indexed-name": "RiviÃ¨re I."
                                },
                                "@author-instance-id": "S0006497121008442-96813d4bbe1d6c0bea83c90e2b2f373b",
                                "@seq": "3",
                                "ce:initials": "I.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "RiviÃ¨re",
                                "@auid": "6701750459",
                                "@orcid": "0000-0002-7363-3963",
                                "ce:indexed-name": "Riviere I."
                            },
                            {
                                "ce:given-name": "Xiuyan",
                                "preferred-name": {
                                    "ce:given-name": "Xiuyan",
                                    "ce:initials": "X.",
                                    "ce:surname": "Wang",
                                    "ce:indexed-name": "Wang X."
                                },
                                "@author-instance-id": "S0006497121008442-0df070dd35a91eb9253ce430bc6b3bb1",
                                "@seq": "5",
                                "ce:initials": "X.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Wang",
                                "@auid": "55736880100",
                                "ce:indexed-name": "Wang X."
                            },
                            {
                                "ce:given-name": "Brigitte",
                                "preferred-name": {
                                    "ce:given-name": "Brigitte",
                                    "ce:initials": "B.",
                                    "ce:surname": "Senechal",
                                    "ce:indexed-name": "Senechal B."
                                },
                                "@author-instance-id": "S0006497121008442-79e940cce8a30027894b63daea9a419e",
                                "@seq": "6",
                                "ce:initials": "B.",
                                "@date-locked": "2022-03-21T17:43:51.446",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Senechal",
                                "@auid": "6701525594",
                                "ce:indexed-name": "Senechal B."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "@afid": "126542363",
                            "organization": [
                                {"$": "Bone Marrow Transplant Service"},
                                {"$": "Department of Pediatrics"}
                            ],
                            "affiliation-id": {
                                "@afid": "126542363",
                                "@dptid": "126766689"
                            },
                            "@affiliation-instance-id": "S0006497121008442-1cc5a49f74b3d59c22c3d87d0538a83e",
                            "ce:source-text": "Bone Marrow Transplant Service, Department of Pediatrics",
                            "@dptid": "126766689"
                        },
                        "author": [{
                            "ce:given-name": "Kevin J.",
                            "preferred-name": {
                                "ce:given-name": "Kevin J.",
                                "ce:initials": "K.J.",
                                "ce:surname": "Curran",
                                "ce:indexed-name": "Curran K.J."
                            },
                            "@author-instance-id": "S0006497121008442-f49d4e0277f3ece22f6539bb908a2551",
                            "@seq": "7",
                            "ce:initials": "K.J.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Curran",
                            "@auid": "7004243164",
                            "ce:indexed-name": "Curran K.J."
                        }]
                    },
                    {
                        "affiliation": {
                            "@afid": "126765716",
                            "organization": {"$": "Cellular Therapeutics Center"},
                            "affiliation-id": {"@afid": "126765716"},
                            "@affiliation-instance-id": "S0006497121008442-7e2a0ae6d345a576b9c9ec57ba5d8e54",
                            "ce:source-text": "Cellular Therapeutics Center"
                        },
                        "author": [
                            {
                                "ce:given-name": "Elizabeth F.",
                                "preferred-name": {
                                    "ce:given-name": "Elizabeth F.",
                                    "ce:initials": "E.F.",
                                    "ce:surname": "Halton",
                                    "ce:indexed-name": "Halton E.F."
                                },
                                "@author-instance-id": "S0006497121008442-abfb5fc4318ea6d9edf45d9a4314d0fe",
                                "@seq": "11",
                                "ce:initials": "E.F.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Halton",
                                "@auid": "54412462100",
                                "ce:indexed-name": "Halton E.F."
                            },
                            {
                                "ce:given-name": "Claudia",
                                "preferred-name": {
                                    "ce:given-name": "Claudia",
                                    "ce:initials": "C.",
                                    "ce:surname": "Diamonte",
                                    "ce:indexed-name": "Diamonte C."
                                },
                                "@author-instance-id": "S0006497121008442-b1b75cff04eae0ea6d3f4911ec358d7b",
                                "@seq": "12",
                                "ce:initials": "C.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Diamonte",
                                "@auid": "57194641550",
                                "ce:indexed-name": "Diamonte C."
                            },
                            {
                                "ce:given-name": "Jae H.",
                                "preferred-name": {
                                    "ce:given-name": "Jae H.",
                                    "ce:initials": "J.H.",
                                    "ce:surname": "Park",
                                    "ce:indexed-name": "Park J.H."
                                },
                                "@author-instance-id": "S0006497121008442-26469a1d7d83c9f3d194e1278af131d3",
                                "@seq": "16",
                                "ce:initials": "J.H.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Park",
                                "@auid": "45561459900",
                                "@orcid": "0000-0002-2903-5130",
                                "ce:indexed-name": "Park J.H."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "organization": {"$": "Department of Pediatrics"},
                            "@affiliation-instance-id": "S0006497121008442-419b921fcbfa62d46aa3503ab2036998",
                            "ce:source-text": "Department of Pediatrics"
                        },
                        "author": [{
                            "ce:given-name": "Kevin J.",
                            "preferred-name": {
                                "ce:given-name": "Kevin J.",
                                "ce:initials": "K.J.",
                                "ce:surname": "Curran",
                                "ce:indexed-name": "Curran K.J."
                            },
                            "@author-instance-id": "S0006497121008442-f49d4e0277f3ece22f6539bb908a2551",
                            "@seq": "7",
                            "ce:initials": "K.J.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Curran",
                            "@auid": "7004243164",
                            "ce:indexed-name": "Curran K.J."
                        }]
                    },
                    {
                        "affiliation": {
                            "@afid": "126765406",
                            "organization": [
                                {"$": "Hematopathology Service"},
                                {"$": "Department of Pathology"}
                            ],
                            "affiliation-id": {
                                "@afid": "126765406",
                                "@dptid": "126766488"
                            },
                            "@affiliation-instance-id": "S0006497121008442-5306401d4347d33e505b61ba48292936",
                            "ce:source-text": "Hematopathology Service, Department of Pathology",
                            "@dptid": "126766488"
                        },
                        "author": [{
                            "ce:given-name": "Mikhail",
                            "preferred-name": {
                                "ce:given-name": "Mikhail",
                                "ce:initials": "M.",
                                "ce:surname": "Roshal",
                                "ce:indexed-name": "Roshal M."
                            },
                            "@author-instance-id": "S0006497121008442-44a783194143809c65c31b4c62cfcdb9",
                            "@seq": "8",
                            "ce:initials": "M.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Roshal",
                            "@auid": "6506624002",
                            "ce:indexed-name": "Roshal M."
                        }]
                    },
                    {
                        "affiliation": {
                            "organization": [
                                {"$": "Immunology Laboratory Service"},
                                {"$": "Department of Laboratory Medicine"}
                            ],
                            "@affiliation-instance-id": "S0006497121008442-383ca5b56724e3bd421b64d53f5d4f12",
                            "ce:source-text": "Immunology Laboratory Service, Department of Laboratory Medicine"
                        },
                        "author": [
                            {
                                "ce:given-name": "Peter G.",
                                "preferred-name": {
                                    "ce:given-name": "Peter G.",
                                    "ce:initials": "P.G.",
                                    "ce:surname": "Maslak",
                                    "ce:indexed-name": "Maslak P.G."
                                },
                                "@author-instance-id": "S0006497121008442-b2b7b952c826c5b1ead51c12b4244712",
                                "@seq": "9",
                                "ce:initials": "P.G.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Maslak",
                                "@auid": "7004235217",
                                "ce:indexed-name": "Maslak P.G."
                            },
                            {
                                "ce:given-name": "Renier J.",
                                "preferred-name": {
                                    "ce:given-name": "Renier J.",
                                    "ce:initials": "R.J.",
                                    "ce:surname": "Brentjens",
                                    "ce:indexed-name": "Brentjens R.J."
                                },
                                "@author-instance-id": "S0006497121008442-81931a3ec3c6eb23fd3079cc48b6c408",
                                "@seq": "15",
                                "ce:initials": "R.J.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Brentjens",
                                "@auid": "6507705992",
                                "ce:indexed-name": "Brentjens R.J."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60009343",
                            "@country": "usa",
                            "city": "New York",
                            "organization": [
                                {"$": "Leukemia Service"},
                                {"$": "Department of Medicine"},
                                {"$": "Memorial Sloan Kettering Cancer Center"}
                            ],
                            "affiliation-id": {
                                "@afid": "60009343",
                                "@dptid": "109501192"
                            },
                            "state": "NY",
                            "@affiliation-instance-id": "S0006497121008442-d82be881566b85af0802083a2f0b0f9f",
                            "ce:source-text": "Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY",
                            "@dptid": "109501192"
                        },
                        "author": [
                            {
                                "ce:given-name": "Mark B.",
                                "preferred-name": {
                                    "ce:given-name": "Mark B.",
                                    "ce:initials": "M.B.",
                                    "ce:surname": "Geyer",
                                    "ce:indexed-name": "Geyer M.B."
                                },
                                "@author-instance-id": "S0006497121008442-3b1194e397f82e1baccafaad3787e355",
                                "@seq": "10",
                                "ce:initials": "M.B.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Geyer",
                                "@auid": "43561336800",
                                "@orcid": "0000-0001-5248-9117",
                                "ce:indexed-name": "Geyer M.B."
                            },
                            {
                                "ce:given-name": "Renier J.",
                                "preferred-name": {
                                    "ce:given-name": "Renier J.",
                                    "ce:initials": "R.J.",
                                    "ce:surname": "Brentjens",
                                    "ce:indexed-name": "Brentjens R.J."
                                },
                                "@author-instance-id": "S0006497121008442-81931a3ec3c6eb23fd3079cc48b6c408",
                                "@seq": "15",
                                "ce:initials": "R.J.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Brentjens",
                                "@auid": "6507705992",
                                "ce:indexed-name": "Brentjens R.J."
                            },
                            {
                                "ce:given-name": "Jae H.",
                                "preferred-name": {
                                    "ce:given-name": "Jae H.",
                                    "ce:initials": "J.H.",
                                    "ce:surname": "Park",
                                    "ce:indexed-name": "Park J.H."
                                },
                                "@author-instance-id": "S0006497121008442-26469a1d7d83c9f3d194e1278af131d3",
                                "@seq": "16",
                                "ce:initials": "J.H.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Park",
                                "@auid": "45561459900",
                                "@orcid": "0000-0002-2903-5130",
                                "ce:indexed-name": "Park J.H."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60007997",
                            "@country": "usa",
                            "city": "New York",
                            "organization": [
                                {"$": "Department of Medicine"},
                                {"$": "Weill Cornell College of Medicine"}
                            ],
                            "affiliation-id": {
                                "@afid": "60007997",
                                "@dptid": "112748380"
                            },
                            "state": "NY",
                            "@affiliation-instance-id": "S0006497121008442-1c769dd382ff66aaafacf96aa5e06e6c",
                            "ce:source-text": "Department of Medicine, Weill Cornell College of Medicine, New York, NY",
                            "@dptid": "112748380"
                        },
                        "author": [
                            {
                                "ce:given-name": "Peter G.",
                                "preferred-name": {
                                    "ce:given-name": "Peter G.",
                                    "ce:initials": "P.G.",
                                    "ce:surname": "Maslak",
                                    "ce:indexed-name": "Maslak P.G."
                                },
                                "@author-instance-id": "S0006497121008442-b2b7b952c826c5b1ead51c12b4244712",
                                "@seq": "9",
                                "ce:initials": "P.G.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Maslak",
                                "@auid": "7004235217",
                                "ce:indexed-name": "Maslak P.G."
                            },
                            {
                                "ce:given-name": "Mark B.",
                                "preferred-name": {
                                    "ce:given-name": "Mark B.",
                                    "ce:initials": "M.B.",
                                    "ce:surname": "Geyer",
                                    "ce:indexed-name": "Geyer M.B."
                                },
                                "@author-instance-id": "S0006497121008442-3b1194e397f82e1baccafaad3787e355",
                                "@seq": "10",
                                "ce:initials": "M.B.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Geyer",
                                "@auid": "43561336800",
                                "@orcid": "0000-0001-5248-9117",
                                "ce:indexed-name": "Geyer M.B."
                            },
                            {
                                "ce:given-name": "Renier J.",
                                "preferred-name": {
                                    "ce:given-name": "Renier J.",
                                    "ce:initials": "R.J.",
                                    "ce:surname": "Brentjens",
                                    "ce:indexed-name": "Brentjens R.J."
                                },
                                "@author-instance-id": "S0006497121008442-81931a3ec3c6eb23fd3079cc48b6c408",
                                "@seq": "15",
                                "ce:initials": "R.J.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Brentjens",
                                "@auid": "6507705992",
                                "ce:indexed-name": "Brentjens R.J."
                            },
                            {
                                "ce:given-name": "Jae H.",
                                "preferred-name": {
                                    "ce:given-name": "Jae H.",
                                    "ce:initials": "J.H.",
                                    "ce:surname": "Park",
                                    "ce:indexed-name": "Park J.H."
                                },
                                "@author-instance-id": "S0006497121008442-26469a1d7d83c9f3d194e1278af131d3",
                                "@seq": "16",
                                "ce:initials": "J.H.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Park",
                                "@auid": "45561459900",
                                "@orcid": "0000-0002-2903-5130",
                                "ce:indexed-name": "Park J.H."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60004803",
                            "@country": "usa",
                            "city": "Tampa",
                            "organization": [
                                {"$": "Department of Malignant Hematology"},
                                {"$": "H. Lee Moffitt Cancer Center and Research Institute"}
                            ],
                            "affiliation-id": {
                                "@afid": "60004803",
                                "@dptid": "105748166"
                            },
                            "state": "FL",
                            "@affiliation-instance-id": "S0006497121008442-d40fd0b6468c3d348b54499f9c89ad8f",
                            "ce:source-text": "Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL",
                            "@dptid": "105748166"
                        },
                        "author": [{
                            "ce:given-name": "Marco L.",
                            "preferred-name": {
                                "ce:given-name": "Marco L.",
                                "ce:initials": "M.L.",
                                "ce:surname": "Davila",
                                "ce:indexed-name": "Davila M.L."
                            },
                            "@author-instance-id": "S0006497121008442-2b8e9b1fc2b9d4005191e9d0713f27cb",
                            "@seq": "13",
                            "ce:initials": "M.L.",
                            "@date-locked": "2022-02-23T13:30:08.621",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Davila",
                            "@auid": "7005656637",
                            "@orcid": "0000-0002-6270-3065",
                            "ce:indexed-name": "Davila M.L."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60009343",
                            "@country": "usa",
                            "city": "New York",
                            "organization": [
                                {"$": "Center for Cell Engineering"},
                                {"$": "Memorial Sloan Kettering Cancer Center"}
                            ],
                            "affiliation-id": {
                                "@afid": "60009343",
                                "@dptid": "106019486"
                            },
                            "state": "NY",
                            "@affiliation-instance-id": "S0006497121008442-d4e3a69a1ac26952252c35c6062e8a11",
                            "ce:source-text": "Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY",
                            "@dptid": "106019486"
                        },
                        "author": [{
                            "ce:given-name": "Michel",
                            "preferred-name": {
                                "ce:given-name": "Michel",
                                "ce:initials": "M.",
                                "ce:surname": "Sadelain",
                                "ce:indexed-name": "Sadelain M."
                            },
                            "@author-instance-id": "S0006497121008442-ac835924a03a3a44ea8bfb433e112f75",
                            "@seq": "14",
                            "ce:initials": "M.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Sadelain",
                            "@auid": "7006509491",
                            "@orcid": "0000-0002-9031-8025",
                            "ce:indexed-name": "Sadelain M."
                        }]
                    }
                ],
                "citation-title": "Interventions and outcomes of adult patients with B-ALL progressing after CD19 chimeric antigen receptor T-cell therapy",
                "abstracts": "Â© 2021 American Society of HematologyCD19-targeted chimeric antigen receptor (CAR) T-cell therapy has become a breakthrough treatment of patients with relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL). However, despite the high initial response rate, the majority of adult patients with B-ALL progress after CD19 CAR T-cell therapy. Data on the natural history, management, and outcome of adult B-ALL progressing after CD19 CAR T cells have not been described in detail. Herein, we report comprehensive data of 38 adult patients with B-ALL who progressed after CD19 CAR T therapy at our institution. The median time to progression after CAR T-cell therapy was 5.5 months. Median survival after post\u2013CAR T progression was 7.5 months. A high disease burden at the time of CAR T-cell infusion was significantly associated with risk of post\u2013CAR T progression. Thirty patients (79%) received salvage treatment of post\u2013CAR T disease progression, and 13 patients (43%) achieved complete remission (CR), but remission duration was short. Notably, 7 (58.3%) of 12 patients achieved CR after blinatumomab and/or inotuzumab administered following post\u2013CAR T failure. Multivariate analysis revealed that a longer remission duration from CAR T cells was associated with superior survival after progression following CAR T-cell therapy. In summary, overall prognosis of adult B-ALL patients progressing after CD19 CAR T cells was poor, although a subset of patients achieved sustained remissions to salvage treatments, including blinatumomab, inotuzumab, and reinfusion of CAR T cells. Novel therapeutic strategies are needed to reduce risk of progression after CAR T-cell therapy and improve outcomes of these patients.",
                "correspondence": {
                    "affiliation": {
                        "country": "United States",
                        "postal-code": "10065",
                        "@country": "usa",
                        "city": "New York",
                        "organization": [
                            {"$": "Leukemia Service"},
                            {"$": "Division of Hematologic Malignancy"},
                            {"$": "Memorial Sloan Kettering Cancer Center"}
                        ],
                        "state": "NY"
                    },
                    "person": {
                        "ce:given-name": "Jae H.",
                        "ce:initials": "J.H.",
                        "ce:surname": "Park",
                        "ce:indexed-name": "Park J.H."
                    }
                },
                "citation-info": {
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "https://www.journals.elsevier.com/blood",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {
                        "$": "Blood",
                        "@xml:lang": "eng"
                    },
                    "volisspag": {
                        "voliss": {
                            "@volume": "138",
                            "@issue": "7"
                        },
                        "pagerange": {
                            "@first": "531",
                            "@last": "543"
                        }
                    },
                    "@type": "j",
                    "sourcetitle": "Blood",
                    "publicationdate": {
                        "month": "08",
                        "year": "2021",
                        "date-text": {
                            "@xfab-added": "true",
                            "$": "19 August 2021"
                        },
                        "day": "19"
                    },
                    "codencode": "BLOOA",
                    "sourcetitle-abbrev": "Blood",
                    "@country": "usa",
                    "issn": [
                        {
                            "$": "15280020",
                            "@type": "electronic"
                        },
                        {
                            "$": "00064971",
                            "@type": "print"
                        }
                    ],
                    "publicationyear": {"@first": "2021"},
                    "publisher": {"publishername": "Elsevier B.V."},
                    "@srcid": "25454"
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "CABSCLASS",
                            "classification": [
                                {
                                    "classification-code": "87.4.11",
                                    "classification-description": "CANCER RESEARCH; TREATMENT; Treatment Monitoring and Evaluation"
                                },
                                {
                                    "classification-code": "87.5.26.1",
                                    "classification-description": "CANCER RESEARCH; CLINICAL INVESTIGATIONS BY ORGAN SITE; Haematologic Malignancies; Leukaemia"
                                }
                            ]
                        },
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "16",
                                    "classification-description": "Cancer"
                                },
                                {
                                    "classification-code": "25",
                                    "classification-description": "Hematology"
                                },
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                },
                                {
                                    "classification-code": "38",
                                    "classification-description": "Adverse Reactions Titles"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": [
                                {"$": "1303"},
                                {"$": "2403"},
                                {"$": "2720"},
                                {"$": "1307"}
                            ]
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": [
                                {"$": "BIOC"},
                                {"$": "IMMU"},
                                {"$": "MEDI"}
                            ]
                        }
                    ]},
                    "chemicalgroup": {"chemicals": [
                        {
                            "@source": "esbd",
                            "chemical": [
                                {
                                    "cas-registry-number": "853426-35-4",
                                    "chemical-name": "blinatumomab"
                                },
                                {
                                    "cas-registry-number": "50-18-0",
                                    "chemical-name": "cyclophosphamide"
                                },
                                {
                                    "cas-registry-number": "21679-14-1",
                                    "chemical-name": "fludarabine"
                                },
                                {
                                    "cas-registry-number": "635715-01-4",
                                    "chemical-name": "inotuzumab ozogamicin"
                                },
                                {
                                    "cas-registry-number": "9001-60-9",
                                    "enzyme-commission-number": "EC 1.1.1.27",
                                    "chemical-name": "lactate dehydrogenase"
                                },
                                {
                                    "enzyme-commission-number": "EC 1.1.1.27",
                                    "chemical-name": "lactate dehydrogenase A"
                                },
                                {
                                    "cas-registry-number": "375823-41-9",
                                    "chemical-name": "tocilizumab"
                                }
                            ]
                        },
                        {
                            "@source": "nlm",
                            "chemical": [
                                {"chemical-name": "Antibodies, Bispecific"},
                                {"chemical-name": "blinatumomab"},
                                {"chemical-name": "Inotuzumab Ozogamicin"}
                            ]
                        }
                    ]}
                },
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "The authors thank the patients who participated in this trial and their families, as well as the staff of the Cell Therapy and Cell Engineering Facility. K.W. receives salary support from the Parker Institute for Cancer Immunotherapy at Memorial Sloan Kettering Cancer Center and King Chulalongkorn Memorial Hospital Thai Red Cross Society, Chulalongkorn University. This work received support from the National Institutes of Health, National Center for Advancing Translational Sciences (grant UL1TR00457; M.B.G.) and the National Cancer Institute (grant P30 CA008748).",
                        "@xml:lang": "eng"
                    }
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2021 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "external-source": "In-Data-Review",
                "dbcollection": [
                    {"$": "CABS"},
                    {"$": "EMBASE"},
                    {"$": "MEDL"},
                    {"$": "REAXYS"},
                    {"$": "REAXYSCAR"},
                    {"$": "RMC"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "18",
                    "@timestamp": "BST 07:29:27",
                    "@year": "2021",
                    "@month": "10"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2014141142",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "634807884",
                            "@idtype": "associatedPUI"
                        },
                        {
                            "$": "2021342478",
                            "@idtype": "CABS"
                        },
                        {
                            "$": "935159947",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20210807894",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "33851211",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "2021256551",
                            "@idtype": "REAXYS"
                        },
                        {
                            "$": "20213128204",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "2021478214",
                            "@idtype": "RMC"
                        },
                        {
                            "$": "20212820702",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "85113169753",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85113169753",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "634807884",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "76273099",
                            "@idtype": "OSIN"
                        }
                    ],
                    "ce:pii": "S0006497121008442",
                    "ce:ern": "pii:S0006497121008442",
                    "ce:doi": "10.1182/blood.2020009515"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "33",
                "reference": [
                    {
                        "ref-fulltext": "Park, JH, RiviÃ¨re, I, Gonen, M, et al. Long-term follow-up of CD19 CAR therapy in acute lymphoblastic leukemia. N Engl J Med 378:5 (2018), 449\u2013459.",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Long-term follow-up of CD19 CAR therapy in acute lymphoblastic leukemia"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib1",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85041377767",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "378",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "449",
                                    "@last": "459"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Park",
                                        "ce:indexed-name": "Park J.H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "I.",
                                        "@_fa": "true",
                                        "ce:surname": "RiviÃ¨re",
                                        "ce:indexed-name": "Riviere I."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Gonen",
                                        "ce:indexed-name": "Gonen M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Park JH, RiviÃ¨re I, Gonen M, et al. Long-term follow-up of CD19 CAR therapy in acute lymphoblastic leukemia. N Engl J Med. 2018; 378(5):449-459."
                    },
                    {
                        "ref-fulltext": "Turtle, CJ, Hanafi, LA, Berger, C, et al. CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients. J Clin Invest 126:6 (2016), 2123\u20132138.",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib2",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84974555520",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "126",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "2123",
                                    "@last": "2138"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Turtle",
                                        "ce:indexed-name": "Turtle C.J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "L.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Hanafi",
                                        "ce:indexed-name": "Hanafi L.A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Berger",
                                        "ce:indexed-name": "Berger C."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Invest"
                        },
                        "ce:source-text": "Turtle CJ, Hanafi LA, Berger C, et al. CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients. J Clin Invest. 2016;126(6):2123-2138."
                    },
                    {
                        "ref-fulltext": "Gardner, RA, Finney, O, Annesley, C, et al. Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults. Blood 129:25 (2017), 3322\u20133331.",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib3",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85019806116",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "129",
                                    "@issue": "25"
                                },
                                "pagerange": {
                                    "@first": "3322",
                                    "@last": "3331"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Gardner",
                                        "ce:indexed-name": "Gardner R.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "O.",
                                        "@_fa": "true",
                                        "ce:surname": "Finney",
                                        "ce:indexed-name": "Finney O."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Annesley",
                                        "ce:indexed-name": "Annesley C."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Gardner RA, Finney O, Annesley C, et al. Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults. Blood. 2017;129(25):3322-3331."
                    },
                    {
                        "ref-fulltext": "Maude, SL, Laetsch, TW, Buechner, J, et al. Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia. N Engl J Med 378:5 (2018), 439\u2013448.",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib4",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85041428116",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "378",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "439",
                                    "@last": "448"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Maude",
                                        "ce:indexed-name": "Maude S.L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.W.",
                                        "@_fa": "true",
                                        "ce:surname": "Laetsch",
                                        "ce:indexed-name": "Laetsch T.W."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Buechner",
                                        "ce:indexed-name": "Buechner J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Maude SL, Laetsch TW, Buechner J, et al. Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia. N Engl J Med. 2018;378(5):439-448."
                    },
                    {
                        "ref-fulltext": "Li, S, Zhang, J, Wang, M, et al. Treatment of acute lymphoblastic leukaemia with the second generation of CD19 CAR-T containing either CD28 or 4-1BB. Br J Haematol 181:3 (2018), 360\u2013371.",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Treatment of acute lymphoblastic leukaemia with the second generation of CD19 CAR-T containing either CD28 or 4-1BB"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib5",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85045219008",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "181",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "360",
                                    "@last": "371"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Li",
                                        "ce:indexed-name": "Li S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Zhang",
                                        "ce:indexed-name": "Zhang J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Wang",
                                        "ce:indexed-name": "Wang M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Br J Haematol"
                        },
                        "ce:source-text": "Li S, Zhang J, Wang M, et al. Treatment of acute lymphoblastic leukaemia with the second generation of CD19 CAR-T containing either CD28 or 4-1BB. Br J Haematol. 2018;181(3):360-371."
                    },
                    {
                        "ref-fulltext": "Cao, J, Wang, G, Cheng, H, et al. Potent anti-leukemia activities of humanized CD19-targeted chimeric antigen receptor T (CAR-T) cells in patients with relapsed/refractory acute lymphoblastic leukemia. Am J Hematol 93:7 (2018), 851\u2013858.",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Potent anti-leukemia activities of humanized CD19-targeted chimeric antigen receptor T (CAR-T) cells in patients with relapsed/refractory acute lymphoblastic leukemia"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib6",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85046009729",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "93",
                                    "@issue": "7"
                                },
                                "pagerange": {
                                    "@first": "851",
                                    "@last": "858"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Cao",
                                        "ce:indexed-name": "Cao J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Wang",
                                        "ce:indexed-name": "Wang G."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Cheng",
                                        "ce:indexed-name": "Cheng H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Am J Hematol"
                        },
                        "ce:source-text": "Cao J, Wang G, Cheng H, et al. Potent anti-leukemia activities of humanized CD19-targeted chimeric antigen receptor T (CAR-T) cells in patients with relapsed/refractory acute lymphoblastic leukemia. Am J Hematol. 2018;93(7):851-858."
                    },
                    {
                        "ref-fulltext": "Curran, KJ, Margossian, SP, Kernan, NA, et al. Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL. [published correction appears in Blood. 2020;136(11):1374]. Blood 134:26 (2019), 2361\u20132368.",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib7",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85077295034",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "134",
                                    "@issue": "26"
                                },
                                "pagerange": {
                                    "@first": "2361",
                                    "@last": "2368"
                                }
                            },
                            "ref-text": "[published correction appears in Blood. 2020;136(11):1374].",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "K.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Curran",
                                        "ce:indexed-name": "Curran K.J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.P.",
                                        "@_fa": "true",
                                        "ce:surname": "Margossian",
                                        "ce:indexed-name": "Margossian S.P."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "N.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Kernan",
                                        "ce:indexed-name": "Kernan N.A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Curran KJ, Margossian SP, Kernan NA, et al. Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL [published correction appears in Blood. 2020;136(11):1374]. Blood. 2019;134(26):2361-2368."
                    },
                    {
                        "ref-fulltext": "Frey, NV, Shaw, PA, Hexner, EO, et al. Optimizing chimeric antigen receptor T-cell therapy for adults with acute lymphoblastic leukemia. J Clin Oncol 38:5 (2020), 415\u2013422.",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Optimizing chimeric antigen receptor T-cell therapy for adults with acute lymphoblastic leukemia"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib8",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85079075868",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "38",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "415",
                                    "@last": "422"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N.V.",
                                        "@_fa": "true",
                                        "ce:surname": "Frey",
                                        "ce:indexed-name": "Frey N.V."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Shaw",
                                        "ce:indexed-name": "Shaw P.A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.O.",
                                        "@_fa": "true",
                                        "ce:surname": "Hexner",
                                        "ce:indexed-name": "Hexner E.O."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Frey NV, Shaw PA, Hexner EO, et al. Optimizing chimeric antigen receptor T-cell therapy for adults with acute lymphoblastic leukemia. J Clin Oncol. 2020;38(5):415-422."
                    },
                    {
                        "ref-fulltext": "Chow, VA, Gopal, AK, Maloney, DG, et al. Outcomes of patients with large B-cell lymphomas and progressive disease following CD19-specific CAR T-cell therapy. Am J Hematol 94:8 (2019), E209\u2013E213.",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Outcomes of patients with large B-cell lymphomas and progressive disease following CD19-specific CAR T-cell therapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib9",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85066906193",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "94",
                                    "@issue": "8"
                                },
                                "pagerange": {
                                    "@first": "E209",
                                    "@last": "E213"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "V.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Chow",
                                        "ce:indexed-name": "Chow V.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.K.",
                                        "@_fa": "true",
                                        "ce:surname": "Gopal",
                                        "ce:indexed-name": "Gopal A.K."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.G.",
                                        "@_fa": "true",
                                        "ce:surname": "Maloney",
                                        "ce:indexed-name": "Maloney D.G."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Am J Hematol"
                        },
                        "ce:source-text": "Chow VA, Gopal AK, Maloney DG, et al. Outcomes of patients with large B-cell lymphomas and progressive disease following CD19-specific CAR T-cell therapy. Am J Hematol. 2019;94(8):E209-E213."
                    },
                    {
                        "ref-fulltext": "Shadman, M, Gauthier, J, Khajavian, S, et al. Relapsed or refractory CLL after CD19-specific CAR-T therapy: treatment patterns and clinical outcomes. Blood, 134(suppl 1), 2019, 4294.",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Relapsed or refractory CLL after CD19-specific CAR-T therapy: treatment patterns and clinical outcomes"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib10",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85107051619",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "134"},
                                "pagerange": {"@first": "4294"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Shadman",
                                        "ce:indexed-name": "Shadman M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Gauthier",
                                        "ce:indexed-name": "Gauthier J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Khajavian",
                                        "ce:indexed-name": "Khajavian S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Shadman M, Gauthier J, Khajavian S, et al. Relapsed or refractory CLL after CD19-specific CAR-T therapy: treatment patterns and clinical outcomes. Blood. 2019; 134(suppl 1):4294."
                    },
                    {
                        "ref-fulltext": "Spiegel, JY, Dahiya, S, Jain, MD, et al. Outcomes of patients with large B-cell lymphoma progressing after axicabtagene ciloleucel. Blood 137:13 (2021), 1832\u20131835.",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Outcomes of patients with large B-cell lymphoma progressing after axicabtagene ciloleucel"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib11",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85100875288",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "137",
                                    "@issue": "13"
                                },
                                "pagerange": {
                                    "@first": "1832",
                                    "@last": "1835"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Spiegel",
                                        "ce:indexed-name": "Spiegel J.Y."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Dahiya",
                                        "ce:indexed-name": "Dahiya S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.D.",
                                        "@_fa": "true",
                                        "ce:surname": "Jain",
                                        "ce:indexed-name": "Jain M.D."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Spiegel JY, Dahiya S, Jain MD, et al. Outcomes of patients with large B-cell lymphoma progressing after axicabtagene ciloleucel. Blood. 2021;137(13):1832-1835."
                    },
                    {
                        "ref-fulltext": "Brentjens, RJ, RiviÃ¨re, I, Park, JH, et al. Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias. Blood 118:18 (2011), 4817\u20134828.",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib12",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "80455179612",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "118",
                                    "@issue": "18"
                                },
                                "pagerange": {
                                    "@first": "4817",
                                    "@last": "4828"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Brentjens",
                                        "ce:indexed-name": "Brentjens R.J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "I.",
                                        "@_fa": "true",
                                        "ce:surname": "RiviÃ¨re",
                                        "ce:indexed-name": "Riviere I."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Park",
                                        "ce:indexed-name": "Park J.H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Brentjens RJ, RiviÃ¨re I, Park JH, et al. Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias. Blood. 2011;118(18):4817-4828."
                    },
                    {
                        "ref-fulltext": "Hollyman, D, Stefanski, J, Przybylowski, M, et al. Manufacturing validation of biologically functional T cells targeted to CD19 antigen for autologous adoptive cell therapy. J Immunother 32:2 (2009), 169\u2013180.",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Manufacturing validation of biologically functional T cells targeted to CD19 antigen for autologous adoptive cell therapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib13",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "63649112916",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "32",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "169",
                                    "@last": "180"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Hollyman",
                                        "ce:indexed-name": "Hollyman D."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Stefanski",
                                        "ce:indexed-name": "Stefanski J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Przybylowski",
                                        "ce:indexed-name": "Przybylowski M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Immunother"
                        },
                        "ce:source-text": "Hollyman D, Stefanski J, Przybylowski M, et al. Manufacturing validation of biologically functional T cells targeted to CD19 antigen for autologous adoptive cell therapy. J Immunother. 2009;32(2):169-180."
                    },
                    {
                        "ref-fulltext": "Goldstone, AH, Richards, SM, Lazarus, HM, et al. In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993). Blood 111:4 (2008), 1827\u20131833.",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib14",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "41349100708",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "111",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "1827",
                                    "@last": "1833"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Goldstone",
                                        "ce:indexed-name": "Goldstone A.H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Richards",
                                        "ce:indexed-name": "Richards S.M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Lazarus",
                                        "ce:indexed-name": "Lazarus H.M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Goldstone AH, Richards SM, Lazarus HM, et al. In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993). Blood. 2008;111(4):1827-1833."
                    },
                    {
                        "ref-fulltext": "Lee, DW, Santomasso, BD, Locke, FL, et al. ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells. Biol Blood Marrow Transplant 25:4 (2019), 625\u2013638.",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib15",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85062342961",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "25",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "625",
                                    "@last": "638"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.W.",
                                        "@_fa": "true",
                                        "ce:surname": "Lee",
                                        "ce:indexed-name": "Lee D.W."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "B.D.",
                                        "@_fa": "true",
                                        "ce:surname": "Santomasso",
                                        "ce:indexed-name": "Santomasso B.D."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "F.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Locke",
                                        "ce:indexed-name": "Locke F.L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Biol Blood Marrow Transplant"
                        },
                        "ce:source-text": "Lee DW, Santomasso BD, Locke FL, et al. ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells. Biol Blood Marrow Transplant. 2019;25(4):625-638."
                    },
                    {
                        "ref-fulltext": "Byrne, M, Oluwole, OO, Savani, B, Majhail, NS, Hill, BT, Locke, FL, Understanding and managing large B cell lymphoma relapses after chimeric antigen receptor T cell therapy. Biol Blood Marrow Transplant 25:11 (2019), e344\u2013e351.",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Understanding and managing large B cell lymphoma relapses after chimeric antigen receptor T cell therapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib16",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85072195380",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "25",
                                    "@issue": "11"
                                },
                                "pagerange": {
                                    "@first": "e344",
                                    "@last": "e351"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Byrne",
                                    "ce:indexed-name": "Byrne M."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "O.O.",
                                    "@_fa": "true",
                                    "ce:surname": "Oluwole",
                                    "ce:indexed-name": "Oluwole O.O."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "B.",
                                    "@_fa": "true",
                                    "ce:surname": "Savani",
                                    "ce:indexed-name": "Savani B."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "N.S.",
                                    "@_fa": "true",
                                    "ce:surname": "Majhail",
                                    "ce:indexed-name": "Majhail N.S."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "B.T.",
                                    "@_fa": "true",
                                    "ce:surname": "Hill",
                                    "ce:indexed-name": "Hill B.T."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "F.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Locke",
                                    "ce:indexed-name": "Locke F.L."
                                }
                            ]},
                            "ref-sourcetitle": "Biol Blood Marrow Transplant"
                        },
                        "ce:source-text": "Byrne M, Oluwole OO, Savani B, Majhail NS, Hill BT, Locke FL,. Understanding and managing large B cell lymphoma relapses after chimeric antigen receptor T cell therapy. Biol Blood Marrow Transplant. 2019;25(11):e344-e351."
                    },
                    {
                        "ref-fulltext": "Pillai, V, Muralidharan, K, Meng, W, et al. CAR T-cell therapy is effective for CD19-dim B-lymphoblastic leukemia but is impacted by prior blinatumomab therapy. Blood Adv 3:22 (2019), 3539\u20133549.",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "CAR T-cell therapy is effective for CD19-dim B-lymphoblastic leukemia but is impacted by prior blinatumomab therapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib17",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85076344065",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "3",
                                    "@issue": "22"
                                },
                                "pagerange": {
                                    "@first": "3539",
                                    "@last": "3549"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "V.",
                                        "@_fa": "true",
                                        "ce:surname": "Pillai",
                                        "ce:indexed-name": "Pillai V."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Muralidharan",
                                        "ce:indexed-name": "Muralidharan K."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "W.",
                                        "@_fa": "true",
                                        "ce:surname": "Meng",
                                        "ce:indexed-name": "Meng W."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood Adv"
                        },
                        "ce:source-text": "Pillai V, Muralidharan K, Meng W, et al. CAR T-cell therapy is effective for CD19-dim B-lymphoblastic leukemia but is impacted by prior blinatumomab therapy. Blood Adv. 2019;3(22):3539-3549."
                    },
                    {
                        "ref-fulltext": "Shah, BD, Bishop, MR, Oluwole, OO, et al. End of phase I results of ZUMA-3, a phase 1/2 study of KTE-X19, anti-CD19 chimeric antigen receptor (CAR) T cell therapy, in adult patients (pts) with relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL). J Clin Oncol, 37(suppl 15), 2019, 7006.",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "End of phase I results of ZUMA-3, a phase 1/2 study of KTE-X19, anti-CD19 chimeric antigen receptor (CAR) T cell therapy, in adult patients (pts) with relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib18",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85078680727",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "37"},
                                "pagerange": {"@first": "7006"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "B.D.",
                                        "@_fa": "true",
                                        "ce:surname": "Shah",
                                        "ce:indexed-name": "Shah B.D."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.R.",
                                        "@_fa": "true",
                                        "ce:surname": "Bishop",
                                        "ce:indexed-name": "Bishop M.R."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "O.O.",
                                        "@_fa": "true",
                                        "ce:surname": "Oluwole",
                                        "ce:indexed-name": "Oluwole O.O."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Shah BD, Bishop MR, Oluwole OO, et al. End of phase I results of ZUMA-3, a phase 1/2 study of KTE-X19, anti-CD19 chimeric antigen receptor (CAR) T cell therapy, in adult patients (pts) with relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL). J Clin Oncol. 2019;37(suppl 15):7006."
                    },
                    {
                        "ref-fulltext": "Thapa, B, Caimi, PF, Ardeshna, KM, et al. CD19 antibody-drug conjugate therapy in DLBCL does not preclude subsequent responses to CD19-directed CAR T-cell therapy. [published correction appears in Blood Adv. 2020;4(19):4606]. Blood Adv 4:16 (2020), 3850\u20133852.",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "CD19 antibody-drug conjugate therapy in DLBCL does not preclude subsequent responses to CD19-directed CAR T-cell therapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib19",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85096132028",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "4",
                                    "@issue": "16"
                                },
                                "pagerange": {
                                    "@first": "3850",
                                    "@last": "3852"
                                }
                            },
                            "ref-text": "[published correction appears in Blood Adv. 2020;4(19):4606].",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Thapa",
                                        "ce:indexed-name": "Thapa B."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P.F.",
                                        "@_fa": "true",
                                        "ce:surname": "Caimi",
                                        "ce:indexed-name": "Caimi P.F."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Ardeshna",
                                        "ce:indexed-name": "Ardeshna K.M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood Adv"
                        },
                        "ce:source-text": "Thapa B, Caimi PF, Ardeshna KM, et al. CD19 antibody-drug conjugate therapy in DLBCL does not preclude subsequent responses to CD19-directed CAR T-cell therapy[published correction appears in Blood Adv. 2020;4(19):4606]. Blood Adv. 2020;4(16):3850-3852."
                    },
                    {
                        "ref-fulltext": "Gardner, RA, Ceppi, F, Rivers, J, et al. Preemptive mitigation of CD19 CAR T-cell cytokine release syndrome without attenuation of antileukemic efficacy. Blood 134:24 (2019), 2149\u20132158.",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Preemptive mitigation of CD19 CAR T-cell cytokine release syndrome without attenuation of antileukemic efficacy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib20",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85076319983",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "134",
                                    "@issue": "24"
                                },
                                "pagerange": {
                                    "@first": "2149",
                                    "@last": "2158"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Gardner",
                                        "ce:indexed-name": "Gardner R.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Ceppi",
                                        "ce:indexed-name": "Ceppi F."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Rivers",
                                        "ce:indexed-name": "Rivers J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Gardner RA, Ceppi F, Rivers J, et al. Preemptive mitigation of CD19 CAR T-cell cytokine release syndrome without attenuation of antileukemic efficacy. Blood. 2019;134(24):2149-2158."
                    },
                    {
                        "ref-fulltext": "Liu, S, Deng, B, Yin, Z, et al. Corticosteroids do not influence the efficacy and kinetics of CAR-T cells for B-cell acute lymphoblastic leukemia. Blood Cancer J, 10(2), 2020, 15.",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Corticosteroids do not influence the efficacy and kinetics of CAR-T cells for B-cell acute lymphoblastic leukemia"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib21",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85079037971",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "10",
                                    "@issue": "2"
                                },
                                "pagerange": {"@first": "15"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Liu",
                                        "ce:indexed-name": "Liu S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Deng",
                                        "ce:indexed-name": "Deng B."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Z.",
                                        "@_fa": "true",
                                        "ce:surname": "Yin",
                                        "ce:indexed-name": "Yin Z."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood Cancer J"
                        },
                        "ce:source-text": "Liu S, Deng B, Yin Z, et al. Corticosteroids do not influence the efficacy and kinetics of CAR-T cells for B-cell acute lymphoblastic leukemia. Blood Cancer J. 2020;10(2):15."
                    },
                    {
                        "ref-fulltext": "Topp, M, Van Meerten, T, Houot, R, et al. Earlier steroid use with axicabtagene ciloleucel (Axi-Cel) in patients with relapsed/refractory large B cell lymphoma. Blood, 134(suppl 1), 2019, 243.",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Earlier steroid use with axicabtagene ciloleucel (Axi-Cel) in patients with relapsed/refractory large B cell lymphoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib22",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85085336006",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "134"},
                                "pagerange": {"@first": "243"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Topp",
                                        "ce:indexed-name": "Topp M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Van Meerten",
                                        "ce:indexed-name": "Van Meerten T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Houot",
                                        "ce:indexed-name": "Houot R."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Topp M, Van Meerten T, Houot R, et al. Earlier steroid use with axicabtagene ciloleucel (Axi-Cel) in patients with relapsed/refractory large B cell lymphoma. Blood. 2019;134 (suppl 1):243."
                    },
                    {
                        "ref-fulltext": "Schuster, SJ, Bartlett, NL, Assouline, S, et al. Mosunetuzumab induces complete remissions in poor prognosis non-Hodgkin lymphoma patients, including those who are resistant to or relapsing after chimeric antigen receptor T-cell (CAR-T) therapies, and is active in treatment through multiple lines. Blood, 134(suppl 1), 2019, 6.",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Mosunetuzumab induces complete remissions in poor prognosis non-Hodgkin lymphoma patients, including those who are resistant to or relapsing after chimeric antigen receptor T-cell (CAR-T) therapies, and is active in treatment through multiple lines"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib23",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85078664985",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "134"},
                                "pagerange": {"@first": "6"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Schuster",
                                        "ce:indexed-name": "Schuster S.J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "N.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Bartlett",
                                        "ce:indexed-name": "Bartlett N.L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Assouline",
                                        "ce:indexed-name": "Assouline S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Schuster SJ, Bartlett NL, Assouline S, et al. Mosunetuzumab induces complete remissions in poor prognosis non-Hodgkin lymphoma patients, including those who are resistant to or relapsing after chimeric antigen receptor T-cell (CAR-T) therapies, and is active in treatment through multiple lines. Blood. 2019;134(suppl 1):6."
                    },
                    {
                        "ref-fulltext": "Chow, VA, Gopal, AK, Gauthier, J, et al. Axicabtagene ciloleucel for relapsed or refractory lymphoma after prior treatment with a different CD19-directed CAR T-cell therapy. Blood Adv 4:19 (2020), 4869\u20134872.",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Axicabtagene ciloleucel for relapsed or refractory lymphoma after prior treatment with a different CD19-directed CAR T-cell therapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib24",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85095729022",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "4",
                                    "@issue": "19"
                                },
                                "pagerange": {
                                    "@first": "4869",
                                    "@last": "4872"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "V.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Chow",
                                        "ce:indexed-name": "Chow V.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.K.",
                                        "@_fa": "true",
                                        "ce:surname": "Gopal",
                                        "ce:indexed-name": "Gopal A.K."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Gauthier",
                                        "ce:indexed-name": "Gauthier J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood Adv"
                        },
                        "ce:source-text": "Chow VA, Gopal AK, Gauthier J, et al. Axicabtagene ciloleucel for relapsed or refractory lymphoma after prior treatment with a different CD19-directed CAR T-cell therapy. Blood Adv. 2020;4(19):4869-4872."
                    },
                    {
                        "ref-fulltext": "Gauthier, J, Bezerra, ED, Hirayama, AV, et al. Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignancies. Blood 137:3 (2021), 323\u2013335.",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignancies"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib25",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85098544846",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "137",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "323",
                                    "@last": "335"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Gauthier",
                                        "ce:indexed-name": "Gauthier J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E.D.",
                                        "@_fa": "true",
                                        "ce:surname": "Bezerra",
                                        "ce:indexed-name": "Bezerra E.D."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.V.",
                                        "@_fa": "true",
                                        "ce:surname": "Hirayama",
                                        "ce:indexed-name": "Hirayama A.V."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Gauthier J, Bezerra ED, Hirayama AV, et al. Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignancies. Blood. 2021;137(3):323-335."
                    },
                    {
                        "ref-fulltext": "Singh, N, Perazzelli, J, Grupp, SA, Barrett, DM, Early memory phenotypes drive T cell proliferation in patients with pediatric malignancies. Sci Transl Med, 8(320), 2016, 320ra3.",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Early memory phenotypes drive T cell proliferation in patients with pediatric malignancies"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib26",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84954566107",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "8",
                                    "@issue": "320"
                                },
                                "pagerange": {"@first": "320ra3"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "N.",
                                    "@_fa": "true",
                                    "ce:surname": "Singh",
                                    "ce:indexed-name": "Singh N."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Perazzelli",
                                    "ce:indexed-name": "Perazzelli J."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "S.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Grupp",
                                    "ce:indexed-name": "Grupp S.A."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "D.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Barrett",
                                    "ce:indexed-name": "Barrett D.M."
                                }
                            ]},
                            "ref-sourcetitle": "Sci Transl Med"
                        },
                        "ce:source-text": "Singh N, Perazzelli J, Grupp SA, Barrett DM,. Early memory phenotypes drive T cell proliferation in patients with pediatric malignancies. Sci Transl Med. 2016;8(320):320ra3."
                    },
                    {
                        "ref-fulltext": "Finney, OC, Brakke, HM, Rawlings-Rhea, S, et al. CD19 CAR T cell product and disease attributes predict leukemia remission durability. J Clin Invest 129:5 (2019), 2123\u20132132.",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "CD19 CAR T cell product and disease attributes predict leukemia remission durability"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib27",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85062816323",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "129",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "2123",
                                    "@last": "2132"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "O.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Finney",
                                        "ce:indexed-name": "Finney O.C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Brakke",
                                        "ce:indexed-name": "Brakke H.M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Rawlings-Rhea",
                                        "ce:indexed-name": "Rawlings-Rhea S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Invest"
                        },
                        "ce:source-text": "Finney OC, Brakke HM, Rawlings-Rhea S, et al. CD19 CAR T cell product and disease attributes predict leukemia remission durability. J Clin Invest. 2019;129(5):2123-2132."
                    },
                    {
                        "ref-fulltext": "Locke, FL, Rossi, JM, Neelapu, SS, et al. Tumor burden, inflammation, and product attributes determine outcomes of axicabtagene ciloleucel in large B-cell lymphoma. Blood Adv 4:19 (2020), 4898\u20134911.",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Tumor burden, inflammation, and product attributes determine outcomes of axicabtagene ciloleucel in large B-cell lymphoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib28",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85095741006",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "4",
                                    "@issue": "19"
                                },
                                "pagerange": {
                                    "@first": "4898",
                                    "@last": "4911"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Locke",
                                        "ce:indexed-name": "Locke F.L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Rossi",
                                        "ce:indexed-name": "Rossi J.M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Neelapu",
                                        "ce:indexed-name": "Neelapu S.S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood Adv"
                        },
                        "ce:source-text": "Locke FL, Rossi JM, Neelapu SS, et al. Tumor burden, inflammation, and product attributes determine outcomes of axicabtagene ciloleucel in large B-cell lymphoma. Blood Adv. 2020;4(19):4898-4911."
                    },
                    {
                        "ref-fulltext": "Deng, Q, Han, G, Puebla-Osorio, N, et al. Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas. Nat Med 26:12 (2020), 1878\u20131887.",
                        "@id": "29",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib29",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85092083293",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "26",
                                    "@issue": "12"
                                },
                                "pagerange": {
                                    "@first": "1878",
                                    "@last": "1887"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Q.",
                                        "@_fa": "true",
                                        "ce:surname": "Deng",
                                        "ce:indexed-name": "Deng Q."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Han",
                                        "ce:indexed-name": "Han G."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Puebla-Osorio",
                                        "ce:indexed-name": "Puebla-Osorio N."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nat Med"
                        },
                        "ce:source-text": "Deng Q, Han G, Puebla-Osorio N, et al. Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas. Nat Med. 2020;26(12):1878-1887."
                    },
                    {
                        "ref-fulltext": "Garfall, AL, Dancy, EK, Cohen, AD, et al. T-cell phenotypes associated with effective CAR T-cell therapy in postinduction vs relapsed multiple myeloma. Blood Adv 3:19 (2019), 2812\u20132815.",
                        "@id": "30",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "T-cell phenotypes associated with effective CAR T-cell therapy in postinduction vs relapsed multiple myeloma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib30",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85073423205",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "3",
                                    "@issue": "19"
                                },
                                "pagerange": {
                                    "@first": "2812",
                                    "@last": "2815"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Garfall",
                                        "ce:indexed-name": "Garfall A.L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E.K.",
                                        "@_fa": "true",
                                        "ce:surname": "Dancy",
                                        "ce:indexed-name": "Dancy E.K."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.D.",
                                        "@_fa": "true",
                                        "ce:surname": "Cohen",
                                        "ce:indexed-name": "Cohen A.D."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood Adv"
                        },
                        "ce:source-text": "Garfall AL, Dancy EK, Cohen AD, et al. T-cell phenotypes associated with effective CAR T-cell therapy in postinduction vs relapsed multiple myeloma. Blood Adv. 2019;3(19):2812-2815."
                    },
                    {
                        "ref-fulltext": "Park, JH, Riviere, I, Sikder, DS, et al. A Phase I study of CD19-targeted 19(T2)28z1xx CAR T cells in adult patients with relapsed or refractory B-cell malignancies. Blood 136:suppl 1 (2020), 43\u201344.",
                        "@id": "31",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "A Phase I study of CD19-targeted 19(T2)28z1xx CAR T cells in adult patients with relapsed or refractory B-cell malignancies"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib31",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85113136224",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "136"},
                                "pagerange": {
                                    "@first": "43",
                                    "@last": "44"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Park",
                                        "ce:indexed-name": "Park J.H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "I.",
                                        "@_fa": "true",
                                        "ce:surname": "Riviere",
                                        "ce:indexed-name": "Riviere I."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Sikder",
                                        "ce:indexed-name": "Sikder D.S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Park JH, Riviere I, Sikder DS, et al. A Phase I study of CD19-targeted 19(T2)28z1xx CAR T cells in adult patients with relapsed or refractory B-cell malignancies. Blood. 2020; 136(suppl 1):43-44."
                    },
                    {
                        "ref-fulltext": "Rafiq, S, Yeku, OO, Jackson, HJ, et al. Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo. Nat Biotechnol 36:9 (2018), 847\u2013856.",
                        "@id": "32",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib32",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85053082722",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "36",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "847",
                                    "@last": "856"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Rafiq",
                                        "ce:indexed-name": "Rafiq S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "O.O.",
                                        "@_fa": "true",
                                        "ce:surname": "Yeku",
                                        "ce:indexed-name": "Yeku O.O."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Jackson",
                                        "ce:indexed-name": "Jackson H.J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nat Biotechnol"
                        },
                        "ce:source-text": "Rafiq S, Yeku OO, Jackson HJ, et al. Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo. Nat Biotechnol. 2018;36(9):847-856."
                    },
                    {
                        "ref-fulltext": "Avanzi, MP, Yeku, O, Li, X, et al. Engineered tumor-targeted T cells mediate enhanced anti-tumor efficacy both directly and through activation of the endogenous immune system. Cell Rep 23:7 (2018), 2130\u20132141.",
                        "@id": "33",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Engineered tumor-targeted T cells mediate enhanced anti-tumor efficacy both directly and through activation of the endogenous immune system"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib33",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85046674047",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "23",
                                    "@issue": "7"
                                },
                                "pagerange": {
                                    "@first": "2130",
                                    "@last": "2141"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.P.",
                                        "@_fa": "true",
                                        "ce:surname": "Avanzi",
                                        "ce:indexed-name": "Avanzi M.P."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "O.",
                                        "@_fa": "true",
                                        "ce:surname": "Yeku",
                                        "ce:indexed-name": "Yeku O."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "X.",
                                        "@_fa": "true",
                                        "ce:surname": "Li",
                                        "ce:indexed-name": "Li X."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cell Rep"
                        },
                        "ce:source-text": "Avanzi MP, Yeku O, Li X, et al. Engineered tumor-targeted T cells mediate enhanced anti-tumor efficacy both directly and through activation of the endogenous immune system. Cell Rep. 2018;23(7):2130-2141."
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "New York",
            "@id": "60009343",
            "affilname": "Memorial Sloan-Kettering Cancer Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009343",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "New York",
            "@id": "60007997",
            "affilname": "Weill Cornell Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007997",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Tampa",
            "@id": "60004803",
            "affilname": "Moffitt Cancer Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60004803",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": null,
            "@id": "126765716",
            "affilname": "Cellular Therapeutics Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126765716",
            "affiliation-country": null
        },
        {
            "affiliation-city": null,
            "@id": "126765627",
            "affilname": "Cell Therapy and Cell Engineering Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126765627",
            "affiliation-country": null
        },
        {
            "affiliation-city": null,
            "@id": "126765406",
            "affilname": "Hematopathology Service",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126765406",
            "affiliation-country": null
        },
        {
            "affiliation-city": "Annaba",
            "@id": "126542363",
            "affilname": "Bone Marrow Transplantation",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126542363",
            "affiliation-country": "Algeria"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85113169753",
        "dc:description": "CD19-targeted chimeric antigen receptor (CAR) T-cell therapy has become a breakthrough treatment of patients with relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL). However, despite the high initial response rate, the majority of adult patients with B-ALL progress after CD19 CAR T-cell therapy. Data on the natural history, management, and outcome of adult B-ALL progressing after CD19 CAR T cells have not been described in detail. Herein, we report comprehensive data of 38 adult patients with B-ALL who progressed after CD19 CAR T therapy at our institution. The median time to progression after CAR T-cell therapy was 5.5 months. Median survival after post\u2013CAR T progression was 7.5 months. A high disease burden at the time of CAR T-cell infusion was significantly associated with risk of post\u2013CAR T progression. Thirty patients (79%) received salvage treatment of post\u2013CAR T disease progression, and 13 patients (43%) achieved complete remission (CR), but remission duration was short. Notably, 7 (58.3%) of 12 patients achieved CR after blinatumomab and/or inotuzumab administered following post\u2013CAR T failure. Multivariate analysis revealed that a longer remission duration from CAR T cells was associated with superior survival after progression following CAR T-cell therapy. In summary, overall prognosis of adult B-ALL patients progressing after CD19 CAR T cells was poor, although a subset of patients achieved sustained remissions to salvage treatments, including blinatumomab, inotuzumab, and reinfusion of CAR T cells. Novel therapeutic strategies are needed to reduce risk of progression after CAR T-cell therapy and improve outcomes of these patients.",
        "pubmed-id": "33851211",
        "prism:coverDate": "2021-08-19",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85113169753",
        "dc:creator": {"author": [{
            "ce:given-name": "Kitsada",
            "preferred-name": {
                "ce:given-name": "Kitsada",
                "ce:initials": "K.",
                "ce:surname": "Wudhikarn",
                "ce:indexed-name": "Wudhikarn K."
            },
            "@seq": "1",
            "ce:initials": "K.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60009343",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009343"
                },
                {
                    "@id": "60028190",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
                }
            ],
            "ce:surname": "Wudhikarn",
            "@auid": "37091810400",
            "author-url": "https://api.elsevier.com/content/author/author_id/37091810400",
            "ce:indexed-name": "Wudhikarn K."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85113169753"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85113169753&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85113169753&origin=inward"
            }
        ],
        "source-id": "25454",
        "pii": "S0006497121008442",
        "citedby-count": "30",
        "prism:volume": "138",
        "subtype": "ar",
        "dc:title": "Interventions and outcomes of adult patients with B-ALL progressing after CD19 chimeric antigen receptor T-cell therapy",
        "openaccess": "1",
        "prism:issn": "15280020 00064971",
        "publishercopyright": "Â© 2021 American Society of Hematology",
        "prism:issueIdentifier": "7",
        "subtypeDescription": "Article",
        "prism:publicationName": "Blood",
        "prism:pageRange": "531-543",
        "prism:endingPage": "543",
        "openaccessFlag": "true",
        "prism:doi": "10.1182/blood.2020009515",
        "prism:startingPage": "531",
        "dc:identifier": "SCOPUS_ID:85113169753",
        "dc:publisher": "Elsevier B.V."
    },
    "idxterms": {"mainterm": [
        {
            "$": "Adult",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Aged",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Antibodies, Bispecific",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Disease-Free Survival",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Female",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Immunotherapy, Adoptive",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Inotuzumab Ozogamicin",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Male",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Middle Aged",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Precursor B-Cell Lymphoblastic Leukemia-Lymphoma",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Salvage Therapy",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Survival Rate",
            "@weight": "b",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": null,
    "subject-areas": {"subject-area": [
        {
            "@_fa": "true",
            "$": "Biochemistry",
            "@code": "1303",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Hematology",
            "@code": "2720",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cell Biology",
            "@code": "1307",
            "@abbrev": "BIOC"
        }
    ]},
    "authors": {"author": [
        {
            "ce:given-name": "Kitsada",
            "preferred-name": {
                "ce:given-name": "Kitsada",
                "ce:initials": "K.",
                "ce:surname": "Wudhikarn",
                "ce:indexed-name": "Wudhikarn K."
            },
            "@seq": "1",
            "ce:initials": "K.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60009343",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009343"
                },
                {
                    "@id": "60028190",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
                }
            ],
            "ce:surname": "Wudhikarn",
            "@auid": "37091810400",
            "author-url": "https://api.elsevier.com/content/author/author_id/37091810400",
            "ce:indexed-name": "Wudhikarn K."
        },
        {
            "ce:given-name": "Jessica R.",
            "preferred-name": {
                "ce:given-name": "Jessica R.",
                "ce:initials": "J.R.",
                "ce:surname": "Flynn",
                "ce:indexed-name": "Flynn J.R."
            },
            "@seq": "2",
            "ce:initials": "J.R.",
            "@_fa": "true",
            "ce:surname": "Flynn",
            "@auid": "57203165820",
            "author-url": "https://api.elsevier.com/content/author/author_id/57203165820",
            "ce:indexed-name": "Flynn J.R."
        },
        {
            "ce:given-name": "Isabelle",
            "preferred-name": {
                "ce:given-name": "Isabelle",
                "ce:initials": "I.",
                "ce:surname": "RiviÃ¨re",
                "ce:indexed-name": "RiviÃ¨re I."
            },
            "@seq": "3",
            "ce:initials": "I.",
            "@_fa": "true",
            "affiliation": {
                "@id": "126765627",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126765627"
            },
            "ce:surname": "RiviÃ¨re",
            "@auid": "6701750459",
            "author-url": "https://api.elsevier.com/content/author/author_id/6701750459",
            "ce:indexed-name": "Riviere I."
        },
        {
            "ce:given-name": "Mithat",
            "preferred-name": {
                "ce:given-name": "Mithat",
                "ce:initials": "M.",
                "ce:surname": "GÃ¶nen",
                "ce:indexed-name": "GÃ¶nen M."
            },
            "@seq": "4",
            "ce:initials": "M.",
            "@_fa": "true",
            "ce:surname": "GÃ¶nen",
            "@auid": "7003560941",
            "author-url": "https://api.elsevier.com/content/author/author_id/7003560941",
            "ce:indexed-name": "Gonen M."
        },
        {
            "ce:given-name": "Xiuyan",
            "preferred-name": {
                "ce:given-name": "Xiuyan",
                "ce:initials": "X.",
                "ce:surname": "Wang",
                "ce:indexed-name": "Wang X."
            },
            "@seq": "5",
            "ce:initials": "X.",
            "@_fa": "true",
            "affiliation": {
                "@id": "126765627",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126765627"
            },
            "ce:surname": "Wang",
            "@auid": "55736880100",
            "author-url": "https://api.elsevier.com/content/author/author_id/55736880100",
            "ce:indexed-name": "Wang X."
        },
        {
            "ce:given-name": "Brigitte",
            "preferred-name": {
                "ce:given-name": "Brigitte",
                "ce:initials": "B.",
                "ce:surname": "Senechal",
                "ce:indexed-name": "Senechal B."
            },
            "@seq": "6",
            "ce:initials": "B.",
            "@_fa": "true",
            "affiliation": {
                "@id": "126765627",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126765627"
            },
            "ce:surname": "Senechal",
            "@auid": "6701525594",
            "author-url": "https://api.elsevier.com/content/author/author_id/6701525594",
            "ce:indexed-name": "Senechal B."
        },
        {
            "ce:given-name": "Kevin J.",
            "preferred-name": {
                "ce:given-name": "Kevin J.",
                "ce:initials": "K.J.",
                "ce:surname": "Curran",
                "ce:indexed-name": "Curran K.J."
            },
            "@seq": "7",
            "ce:initials": "K.J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "126542363",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126542363"
            },
            "ce:surname": "Curran",
            "@auid": "7004243164",
            "author-url": "https://api.elsevier.com/content/author/author_id/7004243164",
            "ce:indexed-name": "Curran K.J."
        },
        {
            "ce:given-name": "Mikhail",
            "preferred-name": {
                "ce:given-name": "Mikhail",
                "ce:initials": "M.",
                "ce:surname": "Roshal",
                "ce:indexed-name": "Roshal M."
            },
            "@seq": "8",
            "ce:initials": "M.",
            "@_fa": "true",
            "affiliation": {
                "@id": "126765406",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126765406"
            },
            "ce:surname": "Roshal",
            "@auid": "6506624002",
            "author-url": "https://api.elsevier.com/content/author/author_id/6506624002",
            "ce:indexed-name": "Roshal M."
        },
        {
            "ce:given-name": "Peter G.",
            "preferred-name": {
                "ce:given-name": "Peter G.",
                "ce:initials": "P.G.",
                "ce:surname": "Maslak",
                "ce:indexed-name": "Maslak P.G."
            },
            "@seq": "9",
            "ce:initials": "P.G.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60007997",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007997"
            },
            "ce:surname": "Maslak",
            "@auid": "7004235217",
            "author-url": "https://api.elsevier.com/content/author/author_id/7004235217",
            "ce:indexed-name": "Maslak P.G."
        },
        {
            "ce:given-name": "Mark B.",
            "preferred-name": {
                "ce:given-name": "Mark B.",
                "ce:initials": "M.B.",
                "ce:surname": "Geyer",
                "ce:indexed-name": "Geyer M.B."
            },
            "@seq": "10",
            "ce:initials": "M.B.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60009343",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009343"
                },
                {
                    "@id": "60007997",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007997"
                }
            ],
            "ce:surname": "Geyer",
            "@auid": "43561336800",
            "author-url": "https://api.elsevier.com/content/author/author_id/43561336800",
            "ce:indexed-name": "Geyer M.B."
        },
        {
            "ce:given-name": "Elizabeth F.",
            "preferred-name": {
                "ce:given-name": "Elizabeth F.",
                "ce:initials": "E.F.",
                "ce:surname": "Halton",
                "ce:indexed-name": "Halton E.F."
            },
            "@seq": "11",
            "ce:initials": "E.F.",
            "@_fa": "true",
            "affiliation": {
                "@id": "126765716",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126765716"
            },
            "ce:surname": "Halton",
            "@auid": "54412462100",
            "author-url": "https://api.elsevier.com/content/author/author_id/54412462100",
            "ce:indexed-name": "Halton E.F."
        },
        {
            "ce:given-name": "Claudia",
            "preferred-name": {
                "ce:given-name": "Claudia",
                "ce:initials": "C.",
                "ce:surname": "Diamonte",
                "ce:indexed-name": "Diamonte C."
            },
            "@seq": "12",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "126765716",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126765716"
            },
            "ce:surname": "Diamonte",
            "@auid": "57194641550",
            "author-url": "https://api.elsevier.com/content/author/author_id/57194641550",
            "ce:indexed-name": "Diamonte C."
        },
        {
            "ce:given-name": "Marco L.",
            "preferred-name": {
                "ce:given-name": "Marco L.",
                "ce:initials": "M.L.",
                "ce:surname": "Davila",
                "ce:indexed-name": "Davila M.L."
            },
            "@seq": "13",
            "ce:initials": "M.L.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60004803",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60004803"
            },
            "ce:surname": "Davila",
            "@auid": "7005656637",
            "author-url": "https://api.elsevier.com/content/author/author_id/7005656637",
            "ce:indexed-name": "Davila M.L."
        },
        {
            "ce:given-name": "Michel",
            "preferred-name": {
                "ce:given-name": "Michel",
                "ce:initials": "M.",
                "ce:surname": "Sadelain",
                "ce:indexed-name": "Sadelain M."
            },
            "@seq": "14",
            "ce:initials": "M.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60009343",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009343"
            },
            "ce:surname": "Sadelain",
            "@auid": "7006509491",
            "author-url": "https://api.elsevier.com/content/author/author_id/7006509491",
            "ce:indexed-name": "Sadelain M."
        },
        {
            "ce:given-name": "Renier J.",
            "preferred-name": {
                "ce:given-name": "Renier J.",
                "ce:initials": "R.J.",
                "ce:surname": "Brentjens",
                "ce:indexed-name": "Brentjens R.J."
            },
            "@seq": "15",
            "ce:initials": "R.J.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60009343",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009343"
                },
                {
                    "@id": "60007997",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007997"
                }
            ],
            "ce:surname": "Brentjens",
            "@auid": "6507705992",
            "author-url": "https://api.elsevier.com/content/author/author_id/6507705992",
            "ce:indexed-name": "Brentjens R.J."
        },
        {
            "ce:given-name": "Jae H.",
            "preferred-name": {
                "ce:given-name": "Jae H.",
                "ce:initials": "J.H.",
                "ce:surname": "Park",
                "ce:indexed-name": "Park J.H."
            },
            "@seq": "16",
            "ce:initials": "J.H.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "126765716",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126765716"
                },
                {
                    "@id": "60009343",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009343"
                },
                {
                    "@id": "60007997",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007997"
                }
            ],
            "ce:surname": "Park",
            "@auid": "45561459900",
            "author-url": "https://api.elsevier.com/content/author/author_id/45561459900",
            "ce:indexed-name": "Park J.H."
        }
    ]}
}}